Call for participants: new NCIRS study on possible links between genes and adverse events after COVID-19 vaccination

Can genetics help predict who will have serious adverse events following COVID-19 vaccination? Help NCIRS find out

NCIRS is seeking participants for a new research study that will investigate the role certain genes may have in predicting which individuals might experience adverse events of special interest (AESI) after COVID-19 vaccination.

The aim of the study is to determine if there are genetic differences between people who experienced an AESI following COVID-19 vaccination – specifically, thrombosis with thrombocytopenia syndrome (TTS), myocarditis/pericarditis or Guillain-Barré syndrome – and those who did not.

NCIRS invites individuals across Australia without medical risk conditions who have had a COVID-19 vaccination and did not experience any serious adverse events to join the study.

Participants will be asked to submit a saliva sample via a self-collection kit for genetic analysis.

The kits will be posted to participants at their nominated address to be completed at home and can be returned via reply-paid postage.

Register your interest in participating here – or, alternatively, contact us directly at SCHN-AusVaxSafety@health.nsw.gov.au.

This research study, which is being conducted by researchers at NCIRS in collaboration with the University of British Columbia (Canada) and the Global Vaccine Data Network, has been approved by Sydney Children’s Hospitals Network (SCHN) HREC 2022/ETH01814.